GOLM1 and liver cancer: Some scholars have studied 229 healthy people, liver cancer, liver cirrhosis and hepatitis patients and found GP73 expression levels in liver cancer and liver cirrhosis patients were significantly higher than in the healthy control group and hepatitis group.34 However, in another 535 studies, the GP73 expression levels in patients with cirrhosis were significantly higher than those in patients with liver cancer and hepatitis, and in the Child‐Pugh classification of cirrhosis, the GP73 levels were significantly higher in patients with grade B and grade C than those with grade A patients.92